A Generic Medicines Sector View on Sustainable Development in Pharmaceuticals - PowerPoint PPT Presentation

Loading...

PPT – A Generic Medicines Sector View on Sustainable Development in Pharmaceuticals PowerPoint presentation | free to view - id: 26ec44-ZDc1Z



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

A Generic Medicines Sector View on Sustainable Development in Pharmaceuticals

Description:

Work together as a team to promote a positive culture where every employee ... Advances in science and technology have brought us tremendous improvements in ... – PowerPoint PPT presentation

Number of Views:70
Avg rating:3.0/5.0

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: A Generic Medicines Sector View on Sustainable Development in Pharmaceuticals


1
(No Transcript)
2
A Generic Medicines Sector View on Sustainable
Development in Pharmaceuticals
  • Uppsala, 10 Nov 2009
  • Sean Bowler
  • VP Engineering and EHS, Actavis

3
Contents
  • The European Generic medicines Association
    Generic Medicines
  • Medicinal Product Life Cycle
  • Specific Challenges for the Generic Sector
  • Actavis How one company manages EHS
  • Way forward

4
The European Generic medicines Association (EGA)

5
The EGA Generic Medicines
  • EGA represents over 700 companies in 34
    European countries
  • Generic medicines companies employ over 130,000
    people in the EU
  • Generic medicines account for nearly 50 of packs
    dispensed in the EU and 18 of pharmaceutical
    expenditure

5
6
Generic Medicines- Key Healthcare Provider
  • Committed to Healthcare and Improvement of Life
    Health Quality
  • Mature and responsible pharmaceutical sector
  • Ensuring access to high-quality affordable
    medicines

6
7
Medicinal PRODUCT LIFE CYCLE

8
Traditional Product Life Cycle
8
9
Product Life Cycle, Pharmaceutical Industry
9
10
Product Life Cycle, Pharmaceutical Industry
10
11
Advantages and Challenges specific to generic
medicines
ADVANTAGES
RESULTING CHALLENGES
  • Established Product (Up to 20 years history)
  • Proven Equivalence
  • Low Cost Supply
  • Greater availability
  • Process Chemistry
  • Costs
  • Raw materials
  • Manufacturing
  • Control of the Value Chain

Life-cycle Management, Outsourcing to non-EU
countries, Operationalising Sustainability,
Minimising the environmental impact of the
business.
11
12
Actavis
EHS OVERVIEW PRESENTATION
13
Actavis Environmental,Health Safety (EHS)
Policy
  • Actavis is committed to operating all aspects of
    its business in a safe and responsible manner
    that protects the environment, and promotes the
    health welfare of employees and the communities
    we operate in.

13
14
Actavis EHS Commitment- Action Plan
  • Establish monitor ambitious objectives and
    targets to prevent occupational injury, illness
    or environmental pollution
  • Proactively manage our EHS risks to ensure
    compliance with all applicable legal and other
    requirements
  • Operate efficiently by integrating EHS
    considerations into our planning and decision
    making
  • Use our flexibility to continuously improve our
    EHS performance
  • Openly communicate our goals and performance to
    all stakeholders, including customers
  • Work together as a team to promote a positive
    culture where every employee accepts personal
    responsibility for EHS

14
15
Actavis EHS Policy Reflected in Strategic
Objectives
  • To fulfil our EHS policy and achieve the vision
    outlined therein, the following strategic
    priorities direct our efforts
  • Improve the Actavis injury illness rate, and
    environmental performance
  • Reduce EHS risks in all Actavis operations
  • Achieve 100 compliance
  • Integrate EHS into the way we do business
  • Continuously improve EHS performance

15
16
Strategy implementation Actavis Environmental,
Health Safety (EHS)
HOW
STRATEGIC OBJECTIVES
  • Continuously improve our incident rate
  • Reduce EHS risks
  • Achieve 100 compliance
  • Implement an independently verifiable EHS
    management system across all operating sites
  • Continuously improve EHS performance
  • Metrics
  • Proactive
  • Reactive
  • Focussed strategic initiatives.
  • Independent Certification
  • Training
  • Auditing program

16
17
Actavis EHS - Performance Control Cycle / PDCA
loop
Set Objectives
Take Corrective action
Continue
Measure
Review progress
17
18
Actavis EHS - Goal Setting
18
19
  • Advances in science and technology have
    brought us tremendous improvements in areas like
    medicineFor all the advantages we have gained
    from our new technologies, we have also witnessed
    many unanticipated side effects.

P.232. AN INCONVENIENT TRUTH, Al Gore. 2006
19
20
Way forward...
  • The EGA is committed to concrete action
  • Providing access to high-quality medicines
    produced in conditions minimising the
    environmental footprint and managed through
    their life-cycle
  • Support EU sustainability initiatives aimed at
    fostering Environment, Health and Safety
    excellence in the pharmaceutical sector

20
21
  • Thank you!
  • Sean Bowler
  • Actavis
  • sebowler_at_actavis.com
About PowerShow.com